A sign bearing the logo of Teva is seen in Jerusalem (Copyright Reuters 2016)
JERUSALEM – Israel's Teva Pharmaceuticals has partnered with Tel Aviv-based Syqe Medical to market in Israel medical cannabis for pain management that is administered with an inhaler.
The companies said in a statement on Monday that this is the first time the medical cannabis sector has complied with pharmaceutical standards for inhalation, which is the most efficient means for administering the plant.
Teva, the world's largest generic drugmaker, will be the exclusive marketer and distributor in Israel of the inhaler developed by Syqe Medical. It will be available for home use pending approvals from the country's Ministry of Health.
Fox News Health
Stay up-to-date on the biggest health and wellness news with our weekly recap.
By entering your email and clicking the Subscribe button, you agree to the Fox News Privacy Policy and Terms of Use, and agree to receive content and promotional communications from Fox News. You understand that you can opt-out at any time.